Hydroxyprogesterone heptanoate benzilic acid hydrazone
|Other names||Hydroxyprogesterone heptanoate benziloylhydrazone; OHPHBH; Hydroxyprogesterone enanthate benzilic acid hydrazone; 17α-Hydroxyprogesterone 17α-heptanoate 3-benzilic acid hydrazone|
|Drug class||Progestin; Progestogen; Progestogen ester|
|Chemical and physical data|
|Molar mass||666.903 g·mol−1|
|3D model (JSmol)|
Hydroxyprogesterone heptanoate benzilic acid hydrazone (OHPHBH), also known as 17α-hydroxyprogesterone 17α-heptanoate 3-benzilic acid hydrazone, is a progestin medication which was never marketed. It is the C3 benzilic acid hydrazone of hydroxyprogesterone heptanoate (OHPH). The medication has a longer duration of action than OHPH when administered by subcutaneous injection in animals.
- Testosterone enantate benzilic acid hydrazone
- List of progestogen esters § Esters of 17α-hydroxyprogesterone derivatives
- Ralph I. Dorfman (3 February 2016). Bioassay. Elsevier. pp. 252–. ISBN 978-1-4832-7276-4.
- Gleason CH, Parker JM (1959). "The duration of activity of the benziloyl hydrazones of testosterone-17-heptanoate, estrone-3-heptanoate and 17α-hydroxy-progesterone-17-heptanoate". Endocrinology. 65 (3): 508–511. doi:10.1210/endo-65-3-508. ISSN 0013-7227. PMID 13828402.
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|